c4c promotes innovation in the design of paediatric clinical trials and quantitative methods in order to foster the development of new medicines in rare paediatric diseases and high medical needs areas.
c4c aims to generate a sustainable infrastructure that optimizes the delivery of clinical trials in children through:
a) a single point of contact for all sponsors, sites and investigators;
b) efficient implementation of trials, adopting consistent approaches, aligned quality standards and coordination of sites at national and international level;
c) collaboration with specialist and national networks;
d) high quality input into study design and preparation, through rigorous strategic and operational feasibility assessment;
e) the promotion of innovative trial design and quantitative scientific methods;
f) an education and training platform to shape the future leaders of paediatric drug development;
g) the development of sustainable support for all these activities.